A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites
Metadatos
Mostrar el registro completo del ítemAutor
Moya-Garzon, Maria Dolores; Wang, Mengjie; Li, Veronica L.; Lyu, Xuchao; Wei, Wei; Tung, Alan Sheng-Hwa; Raun, Steffen H.; Zhao, Meng; Coassolo, Laetitia; Islam, Hashim; Oliveira, Barbara; Dai, Yuqin; Spaas, Jan; Delgado-Gonzalez, Antonio; Donoso, Kenyi; Alvarez-Buylla, Aurora; Franco-Montalban, Francisco; Anudari, Anudari; Ward, Catherine P.; Liu, Lichao; Svensson, Katrin J.; Goldberg, Emily L.; Gardner, Christopher D.; Little, Jonathan P.; Banik, Steven M.; Xu, Yong; Long, Jonathan Z.Materia
BHB metabolomics enzyme obesity ketone metabolite 
Fecha
2025-01-09Patrocinador
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USAResumen
β-Hydroxybutyrate (BHB) is an abundant ketone body. To date, all known pathways of BHB metabolism involve the interconversion of BHB and primary energy intermediates. Here, we identify a previously undescribed BHB secondary metabolic pathway via CNDP2-dependent enzymatic conjugation of BHB and free amino acids. This BHB shunt pathway generates a family of anti-obesity ketone metabolites, the BHB-amino acids. Genetic ablation of CNDP2 in mice eliminates tissue amino acid BHB-ylation activity and reduces BHB-amino acid levels. The most abundant BHB-amino acid, BHB-Phe, is a ketosis-inducible congener of Lac-Phe that activates hypothalamic and brainstem neurons and suppresses feeding. Conversely, CNDP2-KO mice exhibit increased food intake and body weight following exogenous ketone ester supplementation or a ketogenic diet. CNDP2-dependent amino acid BHB-ylation and BHB-amino acid metabolites are also conserved in humans. Therefore, enzymatic amino acid BHB-ylation defines a ketone shunt pathway and bioactive ketone metabolites linked to energy balance.





![pdf [PDF]](/themes/Mirage2/images/thumbnails/mimes/pdf.png)






